WNT7A and breast cancer: We also observed a significant decrease in the expression of some WNT ligands (WNT7A and WNT7B) in DEK silenced PC-3 cells, which is consistent with the findings of a recent study in breast cancer that DEK can drive the proliferation of cells through stimulated expression and secretion of Wnt ligands [31].